(Q44786505)

6 December 2017

title

Attenuation of leukocyte beta 2-integrin expression by antithrombin-III. (English)

1 reference

6 December 2017

D Gritti

1

1 reference

6 December 2017

A Malinverno

2

1 reference

6 December 2017

C Gasparetto

3

1 reference

6 December 2017

C J Wiedermann

4

1 reference

6 December 2017

R Ricevuti

5

1 reference

6 December 2017

publication date

1 January 2004

1 reference

International Journal of Immunopathology and Pharmacology

6 December 2017

published in

1 reference

6 December 2017

volume

17

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

27-32

1 reference

Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

A randomized trial of antithrombin concentrate for treatment of heparin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Activated neutrophils and platelet microaggregates impede blood filterability through microchannels during simulated extracorporeal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Syndecan-4 as antithrombin receptor of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Neutrophils: molecules, functions and pathophysiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Immunodeficiency diseases caused by defects in phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

CD40 Ligand-Dependent Maturation of Human Monocyte-Derived Dendritic Cells by Activated Platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Pathophysiology of ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

The pro-inflammatory seven-transmembrane segment receptors of the leukocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

Antithrombin: a new look at the actions of a serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200401700104

10.1177/039463200401700104

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference